Chronic pain is a worldwide epidemic that disproportionately affects women. These surgeons have found innovative solutions - ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare providers address pain management. Suzetrigine, also known as Journavx, is ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

These laws allow many people with chronic ... acute pain in adults. Journavx should be an important new treatment option to ...

Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.

Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Daily monitoring of the acute:chronic workload ratio is a valid tool for injury risk management in Australian football. The schedule of training and competition should be considered when choosing the ...